IFNG and neoplasm: Porta et al. (33) also demonstrated tumor-derived PGE2 mediated induction of nuclear p50 NF-κB epigenetically reprograms the response of monocytic cells to IFN-γ toward an immunosuppressive phenotype, thus retrieving the anticancer properties of IFN-γ.